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Abstract
Background: Innovative strategies are needed to reduce malaria mortality in high burden countries like Nigeria.
Given that one of the important reasons for this high malaria mortality is delay in receiving effective treatment,
improved access to such treatment is critical. Intramuscular artesunate could be used at lower-level facilities given
its proven efficacy, ease of use and excellent safety profile. The objective of this study was therefore to explore
health workers’ perspectives on the possible use of intramuscular artesunate as definitive treatment for severe
malaria at lower-level facilities, especially when access to referral facilities is challenging. The study was to provide
insight as a formative step into the conduct of future experimental studies to ascertain the feasibility of the use of
intramuscular artesunate for definitive treatment of severe malaria in lower level facilities where access to referral
care is limited.
Methods: This qualitative study was done across three southern States in Nigeria (Oyo, Cross River and Enugu). Key
informant interviews were conducted over a period of three months between October and December 2014 among
90 purposively selected health workers with different roles in malaria case management from primary care to policy
level. A thematic content analysis was used to analyse data.
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Results: Overall, most of health workers and other key informant groups thought that the use of intramuscular
artesunate for definitive treatment of severe malaria at lower-level facilities was possible. They however reported
human resource and infrastructure constraints as factors affecting the feasibility of intramuscular artesunate use as
definitive treatment for severe malaria in lower-level facilities.. Specifically identified barriers included limited
numbers of skilled health workers available to manage potential complications of severe malaria and poorly
equipped facilities for supportive treatment. Intramuscular artesunate was considered easy to administer and the
proximity of lower-level facilities to communities was deemed important in considering the possibility of its use at
lower-level facilities. Health workers also emphasised the important role of operational research to provide additional
evidence to guide the implementation of existing policy recommendations and inform future policy revisions.
Conclusions: From the perspective of health workers, use of intramuscular artesunate for definitive treatment of severe
malaria at lower-level health facilities in Nigeria is possible but dependent on availability of skilled workers, well-
equipped lower-level facilities to provide supportive treatment There is need for further operational research to
establish feasibility and guide the implementation of such an intervention.
Keywords: Intramuscular artesunate, Severe malaria, Lower-level facilities, Poor referral systems, Qualitative study
Background
Morbidity and mortality due to severe malaria remains
disproportionately high in sub-Saharan Africa, with
about 90 % of the world’s severe and fatal cases affecting
young children in this region [1]. Despite modest im-
provements in the last decade, malaria still remains a
major public health problem in Nigeria. In 2013 alone,
about 7.8 million confirmed malaria cases 6000 malaria
deaths were reported in Nigeria [2]. With a population
of approximately 172 million, the country continues to
report more deaths due to malaria than any other coun-
try in the world [2]. As delay in receiving effective treat-
ment is a major driver of this high malaria mortality [3],
improved access to prompt and appropriate treatment is
critical to reducing deaths attributable to malaria. A re-
view of hospital records in tertiary facilities in western
Nigeria indicate that 11.3 % of hospital admissions were
due to severe malaria with 89 % being children less than
5 years of age [4].
In Nigeria, three different health care levels exist with
each having a well-defined role in the continuum of care
for malaria cases in the communities served. These in-
clude primary (lower), secondary and tertiary (referral)
care levels respectively. Primary care facilities (lower-level
facilities) are the entry points for formal health service up-
take and are often most accessible to the communities.
The clinical cadres of personnel commonly found at the
primary care level include junior and senior community
health extension workers (CHEWs); community health of-
ficers (CHOs); Nurses/Midwives; public health nurses and
medical doctors. CHEWs are cadre of health workers with
two-year basic training on community mobilization, man-
agement of common ailments and pre-referral treatments.
CHOs are experienced CHEWs or Nurses with additional
one-year management training on primary healthcare de-
livery. The number and cadre available at any given
primary health facility vary and depend on the category of
primary facility, which include health post (HPs)-expected
to have at least one CHEW; primary health clinic (PHCs)
offering largely out-patient services with at least six
CHEWs. Comprehensive health centres (CHCs) are the
third category with nine CHEWs, one CHO, one public
health nurse, three nurses/midwives and a medical doctor.
The CHC in most cases have in-patient and maternity
services. The anticipated service benchmarks, mini-
mum infrastructure and human resource requirements
stated above (are set by the national primary care mini-
mum service package [5]. However, previous health fa-
cility assessments at this primary level of care have
shown wide variations in service delivery context in re-
lation to these set benchmarks [6–8]. The primary
health care level provides pre-referral treatment for
severe malaria cases [4, 9] and also extends into the
community with CHEWs mandated to spend a propor-
tion of their time in communities within the catchment
area of the primary health care facilities. CHEWs also
supervise a broad range of resident community health
volunteers or community caregivers, who predomin-
antly manage cases of uncomplicated malaria. Second-
ary and tertiary care facilities offer comprehensive
health care and definitive management for both uncom-
plicated and severe malaria [9].
According to WHO handbook on severe malaria, se-
vere falciparum malaria is defined as a patient with
parasitological confirmed malaria who has one or more
of the following clinical features: impaired conscious-
ness; prostration; more than two convulsive episodes
within 24 h; metabolic acidosis; acute pulmonary
oedema and acute respiratory distress syndrome; circula-
tory collapse or shock (systolic blood pressure <80 mm
Hg in adults & < 50 mmHg in children); severe anaemia
(Hb <5gm/dl or haematocrit <15), renal impairment;
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jaundice and abnormal bleeding. the Nigerian national
malaria treatment guidelines for pre-referral treatment
options for severe malaria in children, in order of prefer-
ence are: intramuscular artesunate (IM AS), rectal arte-
sunate or intramuscular quinine [9]. Intravenous or
intramuscular artesunate is used for definitive treatment
of severe malaria at higher-level health facilities. It is ad-
ministered as Intravenous/Intramuscular 2.4 mg/kg is
given initially at time 0, then at 12 h and 24 h and then
daily until the patient can tolerate oral medications with
a full three-day course of Artemisinin-based combin-
ation therapy (ACTs) [9].
In resource-poor settings found in many parts of
Nigeria, healthcare workers are faced with making po-
tentially life-saving decisions related to the management
of severe malaria. Some of these include making referrals
in the presence of uncertainty of availability of timely re-
ferral services which could potentially further put the
patient at risk. It is within this context that pre-referral
treatment, which potentially could offer the patient more
time in the presence of any delays in receiving appropri-
ate definitive treatment for severe malaria, is recom-
mended. However, even with such recommendations,
health systems challenges exist that negatively impact on
clinical outcomes. In these settings, referral practices are
often sub-optimal [6–8, 10], hampered by poor transpor-
tation networks and long distances to referral centres.
Consequently, transit time to referral facilities may be
prolonged leading to delays in initiation of definitive
treatment resulting in deaths [11].
In view of the constraints related to timely access to
definitive and supportive care at referral facilities, defini-
tive management of severe malaria in primary facility
settings maybe necessary in the absence of accessible re-
ferral to secondary and tertiary facilities. The provision
of definitive treatment at lower-level health facilities
could further shorten potential waiting times and reduce
the occurrence of incomplete treatment resulting from
failure to access definitive treatment after initial pre-
referral administration of artesunate, especially within
settings with poor access to proper referral facilities.
Definitive treatment of severe malaria with IM AS at
lower-level facilities within this context may present a
life-saving option to be considered given its efficacy, ease
of administration and excellent safety profile [12, 13].
Deployment of such an intervention needs to be in-
formed by contextual evidence of where and when the
intervention is most appropriate. There is currently lim-
ited information on stakeholder perspectives and views
on the use of IM AS in resource-limited settings. Explor-
ing health worker perspectives on the possibility of IM
AS use at lower-level facilities is an important step in
determining if and where this approach could be consid-
ered as an option. The objective of this study was
therefore to assess health workers’ perspectives on the
possible use of IM AS for definitive treatment of severe
malaria in lower-level health facilities.
Methods
Study sites
This qualitative study was conducted in three southern
States in Nigeria (Oyo, Cross River and Enugu) as part
of the Improving Severe Malaria Outcomes (ISMO) pro-
ject which has an overall goal to reduce mortality from
severe malaria in Ethiopia, Nigeria and Uganda. The
states were purposively selected to represent areas of the
country with malaria control intervention focused at
strengthening the management of severe malaria.
Sample and participants
Study participants were drawn from key influencers who
held roles in the management of severe malaria. They
were identified through a preliminary stakeholder ana-
lysis and include: state-level policy makers, academia,
development and implementing partners’ technical staff,
facility-based health workers and community caregivers.
Policy makers included management and programme
staff at the Ministry of Health and hospital management
boards. Academia comprised of academic staff in teach-
ing hospitals and other medical training institutions.
Facility-based health workers included medical staff at
the primary, secondary and tertiary health facility levels.
The sampling procedures are as stated below:
Policy makers: 24 (eight in each state) key
department/unit heads were purposively selected for
interview in the Ministry of Health (MOH) and
hospital management board (HMB), based on their
involvement in malaria interventions in the three states.
Academia: Six academics, one each from all of the
teaching hospitals in the three states were purposively
selected based on their research interest in malaria.
Malaria implementation partners: Nine technical staff
in each of malaria control implementing partners in
the three states were purposively selected.
Secondary health facilities selection: A random
sample of 6 facilities (2 from each of the 3 States)
were selected from a sample frame of thirty-six (36)
facilities with evidence of prior training of health
workers on the definitive management of severe malaria,
according to national malaria treatment guidelines. The
sample frame was compiled from training database
provided by the three state ministries of health for
trainings done within 6 months prior to the interview.
Primary health facilities selection: A multi-stage
sampling process was used for selection of health
workers from primary-level health facilities. Stage 1
involved random selection of 1 local Government
Adesoro et al. BMC Health Services Research  (2016) 16:566 Page 3 of 11
Area (LGA) from sample of all LGAs in each State.
Stage 2: List of all primary facilities in each selected
LGA with staff trained on the treatment of malaria
within a period of 6 months prior to the interview
was compiled as sampling frame, 1 facility was
randomly selected in the selected LGA, bringing the
total to 3 primary health facilities sampled.
Community caregivers selection: All the community
caregivers under the supervision of the selected LGA
were selected for interview. Each primary facility
supervised a minimum of 6 caregivers.
In each selected facility, all consenting clinical workers
on duty were selected for interview until all available re-
spondents at the time of the visit were interviewed. In-
terviews in each health facility were conducted over a
maximum of two days depending on the availability and
willingness of the clinical staff to take part in the
study. Teams of interviewers moved from one facility
or office to another to conduct interviews, thus, each
team covered a given number of health facilities. Half
of the participant were facility-based health workers
and the remainder were policy makers, academicians and
community-based caregivers as outlined in Table 1.
Prior to interviews, meetings were held with officials
of the malaria control unit of the state Ministry of
Health in the three states to provide more information
and to seek approval to conduct the study and agree on
modalities for the study. Heads of the selected facilities
were contacted on phone to give notice, secure appoint-
ments for interviews and agree on convenient visiting
period, bearing in mind the work load and schedules at
the facilities. Participants in the academic institutions
were contacted for interview appointments in their indi-
vidual capacities.
Data collection
Data was collected by trained research assistants in each
state, using a key informant interview guide that was
developed and pre-tested by the research team. Re-
search assistants were trained for a period of three days
on the study protocol, interviewing skills and note-
taking. Training events conducted included hands-on
sessions, practical demonstration exercises and role
plays. A pre-test was conducted on the data collection
tools in Enugu state. The key informant interview guide
was pre-tested among twelve health workers across the
categories of the targeted respondents to ensure that
questions were non-ambiguous and collected the data
required to answer the research questions. Following
the pre-test, no significant changes were made to the
tools as it was found suitable for collecting the data.
The pre-test interviews were not included in the final
sample of the interviews conducted. The interviews
explored knowledge and views about IM AS use for
management of severe malaria at lower-level facilities;
perceived benefits and barriers and strategies to address
the barriers. Interviews were conducted in English in a
quiet and private environment, devoid of distractions.
Data was collected over a period of three months be-
tween October and December 2014. Interviews were
conducted in English in a quiet and private environment,
devoid of distractions. The interview guide predomin-
antly had open-ended questions and the average dur-
ation of each interview was 30 min. During the data
collection, the research assistants worked in pairs con-
sisting of an interviewer and a note-taker. Interviews
were audio-recorded to ensure no information was
missed. Daily team meetings were held to discuss field
experiences and review daily activities and quality of
work with remedial actions taken where necessary.
Data processing and analysis
Audio recordings from interviews were transcribed ver-
batim by the research assistants and supplemented with
notes taken during the interview. The interviews were
reviewed against audio recordings by the research coord-
inator to ensure consistency, completeness and quality.
This information was typed and saved electronically in
password-protected files. A thematic content analysis
was conducted and data was coded and summarised into
emerging themes based on the questions asked, by creat-
ing a data table from each transcript. A four-member
study team conducted the coding exercise; similar themes
were categorized together based on the frequency of re-
currence and connection. Data that was less frequent,
unique and divergent, was also scrutinized. The study
team held discussions to gain more comprehension of the
emerging themes and to draw comparisons on the most
important themes. A code book was developed to outline
the themes and sub-themes. Verbatim quotes were used
to illustrate the themes and sub-themes (Additional file 1).
Ethical considerations
Ethical approval for this study was obtained from the
National Health Research Ethics committee of the
Federal Ministry of Health, Abuja (Protocol approval
number NHREC/01/01/2007-01/12/2014). Permission to
conduct the study was also obtained from the malaria
control authorities in each of the three participating
States. Participation in the study was voluntary and writ-
ten informed consent was obtained from all the partici-
pants. Permission for audio-recording interviews was
also obtained at the start of each interview. Identifying
information as not recorded for any of the participants.
Instead, pseudonyms were used to protect the partici-
pants’ identity and to ensure that the data could not be
linked back to them.
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Table 1 Profile of key informant
Category Gender Average
age
(Years)
Experience
in current
position
(Av. Years)
Highest educational qualification Number of Participants (N = 90)
Male Female Post-graduate Graduate/professional
qualification
Secondary/High
School
Primary/Basic
school
Cadre Cross River Enugu Oyo Total
Policy Makers 12 6 50.44 3 15 3 0 0 Director 3 6 6 15
Manager 1 1 1 3
Academia 3 3 44.83 12 3 0 0 0 Medical Doctor 1 1 1 3
Nurse 2 0 0 2
Pharmacist 1 0 0 1
Partners 3 6 42.33 2 6 0 0 0 Medical Doctor 2 2 5 9
Secondary Facility Workers 11 15 41.31 7 3 23 0 0 Medical Doctor 4 2 5 11
Nurse 2 3 3 8
Pharmacist 1 3 3 7
Primary Facility Workers 5 14 43.32 12 0 19 0 0 Medical Doctor 2 0 0 2
Nurse 5 1 3 9
CHEW 3 4 1 8
Community Caregivers 1 11 43.33 3 0 1 7 4 Volunteers 0 5 7 12
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Results
From the narratives, participants identified a number of
perceived benefits and challenges related to the introduc-
tion of IM AS for definitive treatment of severe malaria at
lower-level health care levels. Broadly, there were four
main themes: human resources barriers; infrastructural
suitability; drug-related profile of IMAS as enabling factor
for its use at lower-level facilities and role of evidence in
driving implementation of policy and policy revision.
Theme 1: Human resource barriers to the implementation
of IM AS at lower-level facilities
A number of human resource issues were commonly
cited as major factors affecting the possible use of IM
AS use at lower-level facilities and this was a key theme
in most of the narratives. Specifically these issues in-
cluded the inadequate numbers and uneven distribution
of health workers, lack of skilled health workers at lower
levels to manage severe malaria complications and the
potential risk of drug misuse for uncomplicated malaria
leading to resistance.
Sub-theme 1.1: Non-availability of health workers as a
barrier to IM AS roll-out at lower-level facilities
The issue of non-availability of skilled health workers at
lower-level health facilities was highlighted as a major bar-
rier to the use of IM AS at this level. For many of the par-
ticipants, availability of skilled health workers was a major
determinant for the use of IM AS at lower-level facilities.
“Most of the lower health facilities in Nigeria are not
properly staffed. Cases whereby unqualified or semi-
qualified staff are found, you cannot leave them to
administer such injection.” Facility-based health
worker from Cross river state
Participants felt strongly that the cadres of health
workers in most of the lower-level health facilities, who
in most cases are CHEWs, were not sufficiently
knowledgeable and skilled to manage severe malaria.
CHEWs undergo a two-year basic training in management
of common ailments using a “standing order” (Ministry of
Health) staff standard operating procedures).
“Cadre of personnel at these lower-level health facilities
are the CHEWs, in most cases who do not have the
comprehensive medical knowledge on management of
patients, their capacity is low, they are not skilled to
know how to constitute and give correct dosage.” Policy
maker from Oyo State
Other participants noted the ability to manage severe
malaria was not necessarily about the facility level, but
the skills of the clinical workers.
“What determines whether they can treat is the health
worker. Any facility that has a doctor or a trained
nurse can carry on with the treatment”. Facility-based
health worker from Enugu State
Sub-theme 1.2: Task shifting as a response to health worker
maldistribution
Some participants acknowledged the uneven distribution
of health workers in the country, with highly skilled staff
preferring to work in the urban areas, while some of the
health facilities in rural areas had unskilled staff. Differ-
ent audience groups suggested that if trained health
workers available at lower-level facilities, they could treat
severe malaria using IM AS if other conditions required
for good clinical management are met. To those with
this opinion, particularly the policy makers, it would
serve as a form of task-shifting to respond to the human
resource for health challenges at this level:
“It is a form of task-shifting because there is concentration
of well trained staff in the cities and incidentally most of
these severe malaria cases occur in those hinterland, so
there is a need to task-shift and train those people who
are in the hinterland with lower-level healthcare facilities
to be able to manage severe cases of malaria.” – Policy
maker from Enugu State
Other participants highlighted that training cadres of
health workers from lower-level health facilities to man-
age severe malaria would be life-saving for rural commu-
nities without access to highly qualified health workers.
“There are so many rural communities that do not
have hospitals; you don’t expect someone who is ill
there to wait until he comes to city before he gets
Injection. If they [health workers] there are taught how
to use IM AS and how to look out for likely
complications, it will be beneficial to mankind.”
Policy maker from Enugu State
Most participants at facility level suggested that with
training the health workers would be able to manage
severe malaria using IM AS. In particular, participants
at lower-level facilities (PHC) felt confident that if they
are empowered in appropriate case management prac-
tices, they would effectively take on this role. PHC
workers stated:
“Give us training and we will have the knowledge.
Provide us with the admission facility like beds,
because the policy said before now, refer when you see
such cases, but when the policy changes and we are
trained, we will able to handle it.” Lower-level health
worker in Oyo State
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Participants stated that a shift in policy allowing first
level health workers to teat severe malaria would em-
power them to start treating severe malaria by providing
the tools and competencies to do so:
“The fundamental reason for referring severe malaria
cases is because we have not been asked to start
treating the cases. Because even where there is doctor,
when the doctor writes the drugs, it is the nurse that
will give the drug. So if they ask us to start treating the
sickness, we would start treating severe malaria cases.”
– Lower-level health worker from Oyo State
There were suggestions that updating the national
malaria treatment guidelines with clearly defined case
definitions of severe malaria would provide a useful
guide for health workers, making it possible for them to
use IM AS at lower care levels. Other participants sug-
gested that severe malaria cases in the absence of ser-
ious complications could receive definitive treatment at
lower-level facilities, while those with serious complica-
tions should receive pre-referral treatment before refer-
ral to higher levels of care.
“They can do it since they are allowed to give IM
injections but the level of severe malaria must be
graded to indicate the stage they can be allowed to
handle.” Policy maker from Cross River State
Sub-theme 1.3: Inability to manage complications
associated with severe malaria
In stark contrast to the proponents of task-shifting in
this study, there were also strongly divergent views
particularly among policy makers who did not support
definitive treatment of severe malaria at lower-level fa-
cilities. There was concern particularly among policy
makers that allowing the roll-out of IM AS at lower-
level facilities would result in cadres who are not suffi-
ciently skilled attempting to manage severe malaria
cases beyond their ability and failing to refer resulting
in increased death.
“They will over-step their boundaries (in treating other
severe cases) and will think they are the same as
doctors and will make them not to refer cases, thereby
making people to die.” - Policy maker from Oyo State.
Additionally, there were concerns that use of IM AS
was not simply a matter of administering injection but
being able to manage resultant complications.
“It is all conditional, it is not just giving injections but
the staff must be able to manage other complications
of malaria. If the staff is properly trained on these
areas and knows the best time to refer – okay [it’s okay
by me] …” – Policy maker from Oyo State
The participants retreated the concern that insuffi-
ciently skilled cadres at lower-level healthcare facilities
would not be in a position to holistically manage the
complications associated with severe malaria.
“If you are treating severe malaria, you are not looking
at injectable AS alone. If a person has severe malaria,
we also have other complications that need to be treated
which they may not be able to treat at these lower
health facilities.” – Academic from Cross River State
“They should not be empowered at all because they
cannot manage other complications that come with
severe malaria but they can give pre-referral treatment
and not the total management of severe malaria.” –
Policy maker from Oyo State
Theme 2: Infrastructural suitability for the use of IM AS at
lower-level facilities
Participants highlighted potential challenges with other
requirements for good and comprehensive service deliv-
ery such as the non-availability of appropriate equipment
including admission beds, drug storage facilities, labora-
tories, oxygen and blood transfusion equipment. As a
facility-based health worker observed:
“The problem is that of the drug, lack of storage
facilities and lack of adequate equipment.”
While the lack of infrastructure was a concern for
some of the participants, close proximity of the lower-
level health facilities to communities was perceived as
a benefit of using IM AS at lower-level health facilities.
Most participants stated that lower-level facilities were
closer in proximity to the general population making
it easier for patients with severe malaria to access
timely care, especially where there are weak or non-
existent services.
“Ït would be nice to have lower-level facilities treat
severe malaria cases because they are nearer to the
people. Community members prefer to go to the
primary health centre and also it reduces the
transportation fare” - academic from Enugu State
Theme 3: Drug-related profile of IM AS
Some participants stated that the non-availability and
inconsistent supply of IM AS due to the high cost, lack
of storage facilities and expiry of drugs before use,
were potential barriers to the use of IM AS at lower-
level facilities.
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Availability of drug, storage-so many, there is no
electricity to maintain it at the right temperature
especially in remote location, since there is less
incident of severe malaria, the possibility of the drug
expiring before use”- A policy maker from Cross
River State.
Some health workers at the facility level across the
three States also expressed the fear that there would be
risk of IM AS misuse by health workers at this lower-
level for treating uncomplicated malaria.
“There is the possibility of using IM AS for any
malaria case which may not even be severe malaria”-
A higher-level health facility worker from Enugu
Other health workers who highlighted the same
concern that misuse would lead to drug resistance
“There may be abuse. It may not be used for severe
malaria alone and may lead to drug resistance” –
An academic from Teaching hospital in Oyo State
Nonetheless, most participants agreed that IM AS has
some positive attributes that make it suitable to be ad-
ministered at lower-level health facilities. Accordingly,
the majority noted that IM AS is easy to administer and
requires less time and medical devices for administra-
tion. They also noted that IM AS administration involve
less procedure than IV AS, so it can be done by nurses
when doctors are not available.
“IM AS has easy administration because a nurse can
easily give an IM instead of waiting for the doctor to
come and give IV – A technical-lead with a partner in
Oyo State
Another perceived benefit across all categories of re-
spondents was that IM AS may be best suited for some
patients such as patients with collapsed veins:
“Is easy to administer, saves time and less skilled
personnel can use it as it helps to avoid looking for
vein in people who are malnourished.” – A higher-
level facility worker in Cross River State
Other responses suggested that IM AS is slower than
intravenous artesunate in action, hence side effects
can easily and quickly be reversed: According to a pol-
icy maker:
“The fact that IM AS is slower in reaction is a benefit
because side effect can easily and quickly be reverse
unlike IV that goes faster into the blood stream.” – A
policy maker in Enugu State
Theme 4: Support for evidence-based review of polices
and implementation of guidelines
The majority of participants supported periodic policy
reviews to expand the use of IM AS to definitive treat-
ment of severe malaria at lower-level facilities. However
they noted that implementation of such a policy change
would only be successful if operational research and
pilot studies informs on the operational feasibility of
proposed modifications to this new approach and sug-
gested changes are made in a consultative manner, tak-
ing on board practical experience and understanding of
the context. Policy makers stated:
“There is a need to have a roundtable discussion, do
some operational research and have some findings. If
the evidence based studies carried out in various areas
come out with various advantages on the treatment of
severe malaria, they should be included.” – A policy
maker from Cross River State
Discussion
The study findings indicate that the health workers and
other respondents felt that definitive treatment with IM
AS in some lower-level facilities may be possible as an
approach to improve treatment outcomes of patients
with severe malaria. The proximity of lower-level facil-
ities and relative ease of access and of administration of
IM AS were stated as making it a potential option to be
explored for use at lower-level health facilities. However,
the heath workers noted that introduction of IM AS at
lower-level could be hindered by inadequate and un-
skilled health workers, lack of equipped facilities, incon-
sistent drug supply and lack of knowledge among health
workers and other supportive measures required for the
management of concomitant serious complications result-
ing from severe malaria at lower-level facilities.
Availability of skilled health workers at these lower-
level facilities with the capacity to manage complications
of severe malaria was considered to be crucial for the ef-
fective use of IM AS and to be able to achieve any antic-
ipated improvements in treatment outcome at lower
levels. At the primary level of care, the difference in
scope and quality of services offered, present both an
opportunity and a threat to effective management of se-
vere malaria, the current status of these lower levels of
care in terms of staffing could be a hindrance to such an
approach [5, 6, 8, 10]. Indeed, recent assessments con-
ducted by National Primary Health Care Development
Agency in Nigeria (NPHCDA) have revealed that these
lower-level health facilities were grossly understaffed and
particularly lacked skilled personnel [6, 7]. Our study be-
gins to highlight some critical issues for consideration in
resource-poor settings that may be important such as
the ability of the health workers at these lower levels to
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correctly recognise and manage severe malaria patients,
which become more relevant in setting with limited ac-
cess to referral health services.
These findings also suggest that additional training of
health care workers at these lower-level facilities prior to
implementation of IM AS to improve their technical
capacity [10, 14] may be needed. Health workers identi-
fied potential skills gaps to include skills for appropriate
diagnosis and recognition of severe malaria and know-
ledge and skills required for the management of
complications associated with severe malaria. These
challenges may be overcome by health worker training
programmes, which have been shown to improve case
management and treatment outcomes [15, 16]. These
programmes could be tailored to include the needs of
different cadre of health workers.
This study found that respondents thought the ease of
IM AS administration and convenience for patients in
circumstances where venous access is challenging made
its use for definitive treatment of severe malaria at the
lower levels amenable. This finding is consistent with a
recent study in DR Congo, where health care providers
perceived the handling and administration of injectable
AS to be easy [17]. In addition, evidence of the non-
inferiority of simplified dosing regimens of IM AS with
once daily dosing for 3 days [13] provide much needed
assurance towards promoting IM administration of AS.
The concern however raised by health workers in the
study about the risk of drug misuse leading to resistance
is pertinent threat and while there is no documented
evidence to suggest that this is yet a problem for IM AS,
it is worth noting as a potential challenge.
The definitive treatment of severe malaria with IM AS
at lower-level facilities was considered possible by re-
spondents due to the close proximity of these health fa-
cilities to communities, thus opening up the possibility
for more prompt access to treatment; however, chal-
lenges were cited with regards to the availability of
requisite equipment for supportive care and treatment
of severe malaria within lower-level facilities. Health fa-
cility infrastructural capacity, availability and adequacy
of essential laboratory services and medicines, other sup-
plies to support appropriate diagnosis and management
of severe malaria are also vital [10, 14]. Deliberate efforts
are required to make some designated lower-level facil-
ities function optimally to be able to provide the re-
quired service, especially in areas with poor access to
referral facilities, this would increase timely access to
parenteral treatment, thus contributing to reduction in
malaria related mortality. The anticipated improved ac-
cess to IM AS, as suggested, closely mirrors the concept
and approach in improving access to integrated commu-
nity case management (iCCM) that has been shown to
increase treatment coverage, improve timeliness of
treatment and reduce mortality [18]. Such innovative in-
terventions are critical in high malaria burden settings
where malaria contributes significantly to mortality espe-
cially among children less than 5 years of age.
The study findings indicate that further research is
needed to inform policy reviews and the practicalities of
implementation at scale at lower-level facilities. This is
crucial as changing malaria policy and translating pol-
icies to practice are generally complex and long pro-
cesses [19, 20]. The important role of evidence in
supporting this process is also highlighted in other na-
tional settings [21]. In the context of this study, the per-
ceived acceptability by the health workers is a good
starting point as it reflects significant support that could
minimise delays in translation of accrued evidence into
appropriate policies changes.
Strength and limitations of the study
The main strength of this study is the qualitative mode
of inquiry used and the diversity of stakeholders purpos-
ively interviewed ranging from frontline health workers,
academics and policy makers. This ensured that the vari-
ous perspectives were taken into account from the
information-rich participants. Some identified limita-
tions of this study include a recognition that the study
only aimed to capture stakeholder perception and opin-
ion on the possibility rather than true feasibility in real
life situations in lower-level facilities, as this could be
different from views expressed. It will therefore be im-
portant to assess feasibility in an experimental study
with a safety component within the context of a pilot
intervention. This study only considered the health
worker perspectives and not the end user perspectives
on the acceptability and feasibility of IM AS use at lower
level facilities, therefore it cannot be construed that their
perspectives on acceptability would be similar.
Whereas the study findings cannot be generalised,
they highlight the important contextual issues on the
possibility of using IM AS at lower-level facilities in
Nigeria and may need to be considered in similar ser-
vice delivery settings. This evidence is useful for the
National Malaria Elimination Programme and its part-
ners in Nigeria to initiate discussions on potential next
steps to operationalise the use of IM AS for definitive
treatment of severe malaria at lower-level facilities
which often serve as the first and only point of care for
many communities.
Conclusion
The findings indicate that use of IM AS for definitive
treatment for severe malaria at Lower-level health facil-
ities in Nigeria is possible. However, the ability to imple-
ment this was premised upon certain conditions being
in place. These conditions include the availability of
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adequate skilled health workers, equipment and sup-
plies for supportive treatment of severe malaria at
lower-level facilities. Specifically, skilled health workers,
refresher training for health workers on use of IM AS
for management of severe malaria and associated com-
plications or co-infections and improvements in infra-
structure for supportive treatment will be crucial for
improving the feasibility of IM artesunate use at lower-
level health facilities. Further operational research is
however needed to better inform optimal implementa-
tion approaches in this setting.
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